Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisa Delbarba

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Kidney International|May 2, 2020
A single center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumoniaFederico Alberici, Elisa Delbarba, Chiara Manenti, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 6, 2023
Sustained post-rituximab B-cell depletion is common in ANCA-associated vasculitis and is affected by sex and renal functionFederica Mescia, Chiara Salviani, Mattia Tonoli, et al.
Journal of the American Society of Nephrology : JASN|March 2, 2021
Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized TrialFrancesco Scolari, Elisa Delbarba, Domenico Santoro, et al.
Kidney International Reports|April 16, 2020
Management of Patients on Dialysis and With Kidney Transplantation During the SARS-CoV-2 (COVID-19) Pandemic in Brescia, ItalyFederico Alberici, Elisa Delbarba, Chiara Manenti, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 7, 2020
Kidney transplant patients with SARS-CoV-2 infection: The Brescia Renal COVID task force experienceNicola Bossini, Federico Alberici, Elisa Delbarba, et al.
Kidney International Reports|June 11, 2020
Persistent Disease Activity in Patients With Long-Standing Glomerular DiseaseElisa Delbarba, Maddalena Marasa, Pietro A Canetta, et al.
Kidney International|May 22, 2020
A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV-2 infectionFederico Alberici, Elisa Delbarba, Chiara Manenti, et al.
Journal of Nephrology|January 24, 2022
SARS-CoV-2 infection in dialysis and kidney transplant patients: immunological and serological responseFederico Alberici, Stefania Affatato, Daniele Moratto, et al.
Autoimmunity Reviews|September 17, 2020
Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?Philipp Gauckler, Jae Il Shin, Federico Alberici, et al.
Kidney International Reports|April 29, 2021
Rituximab in Membranous NephropathyPhilipp Gauckler, Jae Il Shin, Federico Alberici, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Kidney International|May 2, 2020
A single center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumoniaFederico Alberici, Elisa Delbarba, Chiara Manenti, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 6, 2023
Sustained post-rituximab B-cell depletion is common in ANCA-associated vasculitis and is affected by sex and renal functionFederica Mescia, Chiara Salviani, Mattia Tonoli, et al.
Journal of the American Society of Nephrology : JASN|March 2, 2021
Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized TrialFrancesco Scolari, Elisa Delbarba, Domenico Santoro, et al.
Kidney International Reports|April 16, 2020
Management of Patients on Dialysis and With Kidney Transplantation During the SARS-CoV-2 (COVID-19) Pandemic in Brescia, ItalyFederico Alberici, Elisa Delbarba, Chiara Manenti, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 7, 2020
Kidney transplant patients with SARS-CoV-2 infection: The Brescia Renal COVID task force experienceNicola Bossini, Federico Alberici, Elisa Delbarba, et al.
Kidney International Reports|June 11, 2020
Persistent Disease Activity in Patients With Long-Standing Glomerular DiseaseElisa Delbarba, Maddalena Marasa, Pietro A Canetta, et al.
Kidney International|May 22, 2020
A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV-2 infectionFederico Alberici, Elisa Delbarba, Chiara Manenti, et al.
Journal of Nephrology|January 24, 2022
SARS-CoV-2 infection in dialysis and kidney transplant patients: immunological and serological responseFederico Alberici, Stefania Affatato, Daniele Moratto, et al.
Autoimmunity Reviews|September 17, 2020
Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?Philipp Gauckler, Jae Il Shin, Federico Alberici, et al.
Kidney International Reports|April 29, 2021
Rituximab in Membranous NephropathyPhilipp Gauckler, Jae Il Shin, Federico Alberici, et al.
Pageof 3